These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3980330)

  • 41. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological indices in antibiotic therapy.
    Barger A; Fuhst C; Wiedemann B
    J Antimicrob Chemother; 2003 Dec; 52(6):893-8. PubMed ID: 14613960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
    Mattie H
    Scand J Infect Dis Suppl; 1990; 74():133-6. PubMed ID: 2129065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship.
    Miller TE
    Eur J Clin Microbiol; 1984 Aug; 3(4):285-7. PubMed ID: 6489320
    [No Abstract]   [Full Text] [Related]  

  • 45. [The antibiogram in hospital practice. Its necessity and usefulness].
    Gambella O
    Quad Sclavo Diagn; 1979 Mar; 15(1):124-32. PubMed ID: 542590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recent acquisitions in antibiotic therapy].
    Klastersky J
    Brux Med; 1973 Oct; 53(10):561-7. PubMed ID: 4761149
    [No Abstract]   [Full Text] [Related]  

  • 47. New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
    Karine de Sousa A; Rocha JE; Gonçalves de Souza T; Sampaio de Freitas T; Ribeiro-Filho J; Melo Coutinho HD
    Microb Pathog; 2018 Oct; 123():368-371. PubMed ID: 30056107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobials, susceptibility testing, and minimum inhibitory concentrations (MIC) in veterinary infection treatment.
    Papich MG
    Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1079-89. PubMed ID: 23890240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.
    Widmer AF; Frei R; Rajacic Z; Zimmerli W
    J Infect Dis; 1990 Jul; 162(1):96-102. PubMed ID: 2355207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New studies in the field of aminoglycosidic aminocyclitol antibiotics.
    Arcamone F; Bertazzoli C; Buogo A; Cassinelli G; Vigevani A
    Panminerva Med; 1974; 16(1-2):9-24. PubMed ID: 4449644
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical evaluation of antibiotics in gynecologic infections].
    Chimura T
    Jpn J Antibiot; 1983 Feb; 36(2):241-8. PubMed ID: 6854937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
    Zurabyan VA; Pavlovich NV; Makarovskaya LN; Ryzhkova VV; Bugaeva OK
    Antibiot Khimioter; 1997; 42(11):22-5. PubMed ID: 9463297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic efficacy in odontogenic infections.
    Gabrielson ML; Stroh E
    J Oral Surg; 1975 Aug; 33(8):607-10. PubMed ID: 1056464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of antimicrobial action.
    Mattie H
    Rev Infect Dis; 1981; 3(1):19-27. PubMed ID: 7221359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future.
    Mazumdar K; Asok Kumar K; Dutta NK
    Int J Antimicrob Agents; 2010 Oct; 36(4):295-302. PubMed ID: 20591629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
    Zhang B
    Eur J Med Chem; 2019 Apr; 168():357-372. PubMed ID: 30826511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins.
    Cascioferro S; Raimondi MV; Cusimano MG; Raffa D; Maggio B; Daidone G; Schillaci D
    Molecules; 2015 Dec; 20(12):21658-71. PubMed ID: 26690095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibacterial activity evaluation of selected essential oils in liquid and vapor phase on respiratory tract pathogens.
    Ács K; Balázs VL; Kocsis B; Bencsik T; Böszörményi A; Horváth G
    BMC Complement Altern Med; 2018 Jul; 18(1):227. PubMed ID: 30053847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brief overview of antibacterial agents.
    Gupta NN; Lakhe MM
    J Assoc Physicians India; 2010 Dec; 58 Suppl():8-12. PubMed ID: 21563607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.